Literature DB >> 15812095

Selection of outcome assessment instruments for inpatients with severe and persistent mental illness.

Gary M Burlingame1, Todd W Dunn, Steven Chen, August Lehman, Reid Axman, Dallas Earnshaw, Frank M Rees.   

Abstract

The purpose of this article is to describe a procedure to assist in selecting outcome measures for inpatients treated at a state psychiatric hospital. The procedure combines evidence-based criteria from the literature, instruments shown to be sensitive to change in clinical trials, and the perspectives of a multidisciplinary team of researchers, administrators, providers, and patient advocates. Recent efficacy and effectiveness studies were used to identify recurrently used outcome instruments. A computerized search of more than 30 bibliographic databases, such as PsycINFO, MEDLINE, Social SciSearch, and ERIC, was conducted for articles published between 1990 and 2002. Comparisons of the most frequently used instruments were made on seven criteria proposed as best-practice indicators, including sensitivity to change and robust psychometrics. The sample produced 110 measures. Rater-completed instruments were represented more often than patient-completed ones. However, considerable variability across both methods was found on the criteria. The limited resources associated with publicly funded inpatient facilities led to a recommendation to select at least one rater-completed and one patient-completed instrument.

Entities:  

Mesh:

Year:  2005        PMID: 15812095     DOI: 10.1176/appi.ps.56.4.444

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  20 in total

1.  Global Assessment of Functioning (GAF): properties and frontier of current knowledge.

Authors:  I H Monrad Aas
Journal:  Ann Gen Psychiatry       Date:  2010-05-07       Impact factor: 3.455

Review 2.  Measurement of functional capacity: a new approach to understanding functional differences and real-world behavioral adaptation in those with mental illness.

Authors:  Thomas L Patterson; Brent T Mausbach
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

3.  Measuring clinically meaningful change following mental health treatment.

Authors:  Susan V Eisen; Gayatri Ranganathan; Pradipta Seal; Avron Spiro
Journal:  J Behav Health Serv Res       Date:  2007-05-30       Impact factor: 1.505

4.  The Hoosier Assurance Plan Instrument for Adults (HAPI-A): the psychometric properties of a level of functioning assessment instrument designed for use in a state managed care mental health program.

Authors:  John McGrew; Frederick L Newman; Richard N DeLiberty
Journal:  Community Ment Health J       Date:  2007-07-10

Review 5.  A review of instruments for measuring functional recovery in those diagnosed with psychosis.

Authors:  Brent T Mausbach; Raeanne Moore; Christopher Bowie; Veronica Cardenas; Thomas L Patterson
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

Review 6.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

7.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

8.  Minimum clinically important difference in the Positive and Negative Syndrome Scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).

Authors:  Eric D A Hermes; Daniel Sokoloff; T Scott Stroup; Robert A Rosenheck
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

9.  Guidelines for rating Global Assessment of Functioning (GAF).

Authors:  I H Monrad Aas
Journal:  Ann Gen Psychiatry       Date:  2011-01-20       Impact factor: 3.455

10.  Is there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysis.

Authors:  Jitsuki Sawamura; Shigeru Morishita; Jun Ishigooka
Journal:  BMC Psychiatry       Date:  2010-12-07       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.